Haemophilus influenzae type b disease in HIV-infected children: A review of the disease epidemiology and effectiveness of Hib conjugate vaccines

Vaccine

Volumn 28, Issue 7, 2010, Pages 1677-1683

  Mangtani, Punam ^a   Mulholland, Kim ^a   Madhi, Shabir A ^b   Edmond, Karen ^a   O'Loughlin, Rosalyn ^a   Hajjeh, Rana ^c,d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NATIONAL RESEARCH FOUNDATION   (South Africa)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

HIb vaccine; HIV; Low income settings; Vaccine schedule

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PNEUMOCOCCUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTEREMIA; BACTERIAL INFECTION; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; MORBIDITY; PHYSICIAN; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SOUTH AFRICA; TREATMENT FAILURE;

ANTI-RETROVIRAL AGENTS; CHILD; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HIV INFECTIONS; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION, SECONDARY; VACCINES, CONJUGATE;

EID: 75349106575     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.12.011     Document Type: Review

References (56)

1. Adegbola R.A., Mulholland E.K., Secka O., Jaffar S., and Greenwood B.M. Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H-influenzae type b among Gambian children. J Infect Dis 177 6 (1998) 1758-1761
2. Takala A.K., Eskola J., Leinonen M., Kayhty H., Nissinen A., Pekkanen E., et al. Reduction of oropharyngeal carriage of Haemophilus-influenzae type-B (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis 164 5 (1991) 982-986
3. Watt J.P., Wolfson L.J., O'Brien K.L., et al. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet 374 (2009) 903-911
4. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO). AIDS epidemic update (2007), UNAIDS. http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en.pdf [last accessed February 2009]
5. Newell M.L., Coovadia H., Cortina-Borja M., Rollins N., Gaillard P., and Dabis F. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 364 9441 (2004) 1236-1243
6. UNICEF. Children and AIDs a stocktaking report (2007), UNICEF, New York
7. Mulenga V., Ford D., Walker A.S., Mwenya D., Mwansa J., Sinyinza F., et al. Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children. AIDS 21 1 (2007) 77-84
8. Obonyo C.O., and Lau J. Efficacy of Haemophilus influenzae type b vaccination of children: a meta-analysis. Eur J Clin Microbiol Infect Dis 25 2 (2006) 90-97
9. Centers for Disease Control and Prevention. Progress toward introduction of Haemophilus influenzae type b vaccine in low-income countries-worldwide, 2004-2007. MMWR 57 6 (2008) 148-151
10. Adegbola R.A., Secka O., Lahai G., Lloyd-Evans N., Njie A., Usen S., et al. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 366 9480 (2005) 144-150
11. Cowgill K.D., Ndiritu M., Nyiro J., Slack M.P., Chiphatsi S., Ismail A., et al. Effectiveness of Haemophilus influenzae type b conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA 296 6 (2006) 671-678
12. von Gottberg A., de Gouveia L., Madhi S.A., du Plessis M., Quan V., Soma K., et al. Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa. Bull World Health Organ 84 10 (2006) 811-818
13. WHO position paper on Haemophilus influenzae type b conjugate vaccines (replaces WHO position paper on Hib vaccines previously published in the Weekly Epidemiological Record). Wkly Epidemiol Rec 81 47 (2006) 445-452
14. WHO. Revised BCG vaccination guidelines for infants at risk for HIV infection. Wkly Epidemiol Rec 82 (2007) 193-196. www.who.int/wer/2007/wer8221.pdf [accessed 30 May 2008]
15. World Health Organization. Measles vaccines: WHO position paper. Bull World Health Organ 79 (2004) 130-142
16. Moss W.J., Clements C.J., and Halsey N.A. Immunization of children at risk of infection with human immunodeficiency virus. Bull World Health Organ 81 (2003) 61-70
17. Spector S.A., Gelber R.D., McGrath N., Wara D., Barzilai A., Abrams E., et al. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. N Engl J Med 331 18 (1994) 1181-1187
18. Bernstein L.J., Ochs H.D., Wedgwood R.J., and Rubinstein A. Defective humoral immunity in pediatric acquired immune deficiency syndrome. J Pediatr 107 3 (1985) 352-357
19. Madhi S.A., Petersen K., Madhi A., Khoosal M., and Klugman K.P. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin Infect Dis 31 1 (2000) 170-176
20. Nathoo K.J., Chigonde S., Nhembe M., Ali M.H., and Mason P.R. Community-acquired bacteremia in human immunodeficiency virus-infected children in Harare, Zimbabwe. Pediatr Infect Dis J 15 12 (1996) 1092-1097
21. Lepage P., Van de P.P., Nsengumuremyi F., Van G.C., Bogaerts J., and Hitimana D.G. Bacteraemia as predictor of HIV infection in African children. Acta Paediatr Scand 78 5 (1989) 763-766
22. Matida L., Marcopito L., de Menezes Succi R., et al. Improving survival among Brazilian children with perinatally-acquired AIDS. Braz J Infect Dis 8 (2004) 419-423
23. Madhi S.A., Madhi A., Petersen K., Khoosal M., and Klugman K.P. Impact of human immunodeficiency virus type 1 infection on the epidemiology and outcome of bacterial meningitis in South African children. Int J Infect Dis 5 3 (2001) 119-125
24. Molyneux E.M., Tembo M., Kayira K., Bwanaisa L., Mweneychanya J., Njobvu A., et al. The effect of HIV infection on paediatric bacterial meningitis in Blantyre, Malawi. Arch Dis Child 88 12 (2003) 1112-1118
25. Klugman K.P., Madhi S.A., Huebner R.E., Kohberger R., Mbelle N., and Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 349 14 (2003) 1341-1348
26. Madhi S.A., Petersen K., Khoosal M., Huebner R.E., Mbelle N., Mothupi R., et al. Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection. Pediatr Infect Dis J 21 4 (2002) 315-321
27. Adegbola R.A., Mulholland E.K., Falade A.G., Secka O., Sarge-Njai R., Corrah T., et al. Haemophilus influenzae type b disease in the western region of The Gambia: background surveillance for a vaccine efficacy trial. Ann Trop Paediatr 16 2 (1996) 103-111
28. Hussey G., Hitchcock J., Schaaf H., Coetzee G., Hanslo D., Van S.E., et al. Epidemiology of invasive Haemophilus influenzae infections in Cape Town, South Africa. Ann Trop Paediatr 14 2 (1994) 97-103
29. Eley B., and Nuttall J. Antiretroviral therapy for children: challenges and opportunities. Ann Trop Paediatr 27 1 (2007) 1-10
30. Kapogiannis B.G., Soe M.M., Nesheim S.R., Sullivan K.M., Abrams E., Farley J., et al. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004). Pediatrics 121 5 (2008) E1229-E1239
31. Madhi S.A., Kuwanda L., Saarinen L., Cutland C., Mothupi R., Kayhty H., et al. Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children. Vaccine 23 48-49 (2005) 5517-5525
32. Daza P., Banda R., Misoya K., Katsulukuta A., Gessner B.D., Katsande R., et al. The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence. Vaccine 24 37-39 (2006) 6232-6239
33. Howie S.R., Antonio M., Akisanya A., Sambou S., Hakeem I., Secka O., et al. Re-emergence of Haemophilus influenzae type b (Hib) disease in The Gambia following successful elimination with conjugate Hib vaccine. Vaccine 25 34 (2007) 6305-6309
34. Kayhty H., Peltola H., Karanko V., and Makela P.H. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 147 6 (1983) 1100
35. Campos J., Aracil B., Roman F., and Perez-Vazquez M. Molecular epidemiology of Haemophilus influenzae type b isolated from children with clinical cases of conjugate vaccine failures. J Clin Microbiol 41 8 (2003) 3915-3918
36. Kale K.L., King Jr. J.C., Farley J.J., Vink P.E., Cimino C.O., and Paradiso P.R. The immunogenicity of Haemophilus influenzae type b conjugate (HbOC) vaccine in human immunodeficiency virus-infected and uninfected infants. Pediatr Infect Dis J 14 5 (1995) 350-354
37. Rutstein R.M., Rudy B.J., and Cnaan A. Response of human immunodeficiency virus-exposed and -infected infants to Haemophilus influenzae type b conjugate vaccine. Arch Pediatr Adolesc Med 150 8 (1996) 838-841
38. Spoulou V.I., Tsoumas D.L., Papaevangelou V.G., Mostrou G.I., and Theodoridou M.C. Haemophilus influenzae type b conjugate vaccine-induced immunological memory in symptomatic HIV-1-infected children. AIDS 17 9 (2003) 1396-1398
39. Read J.S., Frasch C.E., Rich K., Fitzgerald G.A., Clemens J.D., Pitt J., et al. The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group. Pediatr Infect Dis J 17 5 (1998) 391-397
40. Peters V.B., and Sood S.K. Immunity to Haemophilus influenzae type b polysaccharide capsule after vaccination with the complete series of oligosaccharide CRM197 conjugate vaccine in infants with human immunodeficiency virus infection. J Pediatr 128 3 (1996) 363-365
41. Obaro S.K., Pugatch D., and Luzuriaga K. Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children. Lancet Infect Dis 4 8 (2004) 510-518
42. Melvin A.J., and Mohan K.M. Response to immunization with measles, tetanus, and Haemophilus influenzae type b vaccines in children who have human immunodeficiency virus type 1 infection and are treated with highly active antiretroviral therapy. Pediatrics 111 6 Pt 1 (2003) e641-e644
43. Violari A., Cotton M.F., Gibb D.M., Babiker A.G., Steyn J., Madhi S.A., et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 359 21 (2008) 2233-2244
44. Gibb D., Spoulou V., Giacomelli A., Griffiths H., Masters J., Misbah S., et al. Antibody responses to Haemophilus influenzae type b and Streptococcus pneumoniae vaccines in children with human immunodeficiency virus infection. Pediatr Infect Dis J 14 2 (1995) 129-135
45. Janoff E.N., Tasker S.A., Stevenson M., Rubins J.B., O'Brien J., Utz G., et al. Immune activation and virologic response to immunization in recent HIV type 1 seroconverters. AIDS Res Hum Retroviruses 15 9 (1999) 837-845
46. Mulholland K., Hilton S., Adegbola R., Usen S., Oparaugo A., Omosigho C., et al. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine for prevention of pneumonia and meningitis in Gambian infants. Lancet 349 9060 (1997) 1191-1197
47. Graham S.M., and Gibb D.M. HIV disease and respiratory infection in children. Br Med Bull 61 (2002) 133-150
48. WHO Vaccine Preventable Diseases Monitoring System Immunization schedules by antigen, selection centre (2009). http://www.who.int/vaccines/globalsummary/immunization/ScheduleSelect.cf m [last accessed January 2009]
49. Munoz P., Miranda M.E., Llancaqueo A., Pelaez T., Rodriguez-Creixems M., and Bouza E. Haemophilus species bacteremia in adults. The importance of the human immunodeficiency virus epidemic. Arch Intern Med 157 16 (1997) 1869-1873
50. The Hib Initiative. http://hibaction.org/maps/hibactivities.php [accessed 10 December 2008, 13-12-2008].
51. Madhi S.A., Klugman K.P., Kuwanda L., Cutland C., Kaeyhty H., and Adrian P. Quantitative and qualitative anamnestic immune responses to pneumococcal conjugate vaccine in HIV-infected and HIV-uninfected children 5 years after vaccination. J Infect Dis 199 8 (2009) 1168-1176
52. Meyers T., Moultrie H., Naidoo K., Cotton M., Eley B., and Sherman G. Challenges to pediatric HIV care and treatment in South Africa. J Infect Dis 196 (2007) S474-S481
53. Peters V.B., and Sood S.K. Immunity to Haemophilus influenzae type b polysaccharide capsule in children with human immunodeficiency virus infection immunized with a single dose of Haemophilus vaccine. J Pediatr 125 1 (1994) 74-77
54. Peters V.B., and Sood S.K. Immunity to Haemophilus influenzae type b after reimmunization with oligosaccharide CRM197 conjugate vaccine in children with human immunodeficiency virus infection. Pediatr Infect Dis J 16 7 (1997) 711-713
55. Gibb D., Giacomelli A., Masters J., Spoulou V., Ruga E., Griffiths H., et al. Persistence of antibody responses to Haemophilus influenzae type b polysaccharide conjugate vaccine in children with vertically acquired human immunodeficiency virus infection. Pediatr Infect Dis J 15 12 (1996) 1097-1101
56. Chokephaibulkit K., Phongsamart W., Vanprapar N., Chotpitayasunondh T., and Chearskul S. Catch-up vaccination against Haemophilus influenzae type b in human immunodeficiency virus-infected Thai children older than 2 years old. Vaccine 22 15-16 (2004) 2018-2022